Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34587765.
- Also identified by DOI 10.1161/CIRCULATIONAHA.121.053521 and PMC identifier 8595845.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Filamin C truncating variants (<i>FLNCtv</i>) cause a form of arrhythmogenic cardiomyopathy: the mode of presentation, natural history, and risk stratification of <i>FLNCtv</i> remain incompletely explored. We aimed to develop a risk profile for refractory heart failure and life-threatening arrhythmias in a multicenter cohort of <i>FLNCtv</i> carriers. <i>FLNCtv</i> carriers were identified from 10 tertiary care centers for genetic cardiomyopathies. Clinical and outcome data were compiled. Composite outcomes were all-cause mortality/heart transplantation/left ventricle assist device (D/HT/LVAD), nonarrhythmic death/HT/LVAD, and sudden cardiac death/major ventricular arrhythmias. Previously established cohorts of 46 patients with <i>LMNA</i> and 60 with <i>DSP</i>-related arrhythmogenic cardiomyopathies were used for prognostic comparison. Eighty-five patients carrying <i>FLNCtv</i> were included (42±15 years, 53% men, 45% probands). Phenotypes were heterogeneous at presentation: 49% dilated cardiomyopathy, 25% arrhythmogenic left dominant cardiomyopathy, 3% arrhythmogenic right ventricular cardiomyopathy. Left ventricular ejection fraction was <50% in 64% of carriers and 34% had right ventricular fractional area changes (RVFAC=(right ventricular end-diastolic area - right ventricular end-systolic area)/right ventricular end-diastolic area) <35%. During follow-up (median time 61 months), 19 (22%) carriers experienced D/HT/LVAD, 13 (15%) experienced nonarrhythmic death/HT/LVAD, and 23 (27%) experienced sudden cardiac death/major ventricular arrhythmias. The sudden cardiac death/major ventricular arrhythmias incidence of <i>FLNCtv</i> carriers did not significantly differ from <i>LMNA</i> carriers and <i>DSP</i> carriers. In <i>FLNCtv</i> carriers, left ventricular ejection fraction was associated with the risk of D/HT/LVAD and nonarrhythmic death/HT/LVAD. Among patients referred to tertiary referral centers, <i>FLNCtv</i> arrhythmogenic cardiomyopathy is phenotypically heterogeneous and characterized by a high risk of life-threatening arrhythmias, which does not seem to be associated with the severity of left ventricular dysfunction.
Medical subject headings
- Cardiomyopathies
- Filamins
- Genetic Predisposition to Disease
- Genetic Variation
- Phenotype